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Everyday thousands of people suffer from bone diseases that lead to destruction of bone 
tissue. Various types of bone allograft, xenograft and synthetic biomaterial are now used 
for bone replacement therapy. The future of bone reconstruction lies in the use of stem 
cell technology for bone development. Within the bone marrow stroma there are exists a 
subset of nonhematopoietic cells referred to as mesenchymal stem cells (MSCs) or 
mesenchymal progenitor cells (MPCs). These cells can be expanded ex vivo and induced, 
either in vitro or in vivo, to terminally differentiate into osteoblasts, chondrocytes, 
adypocytes, tenocytes, myotubes, neural cells, and hematopoietic supporting stroma. The 
multipotential of these cells, their easy collection and culture, as well as their high ex vivo 
expansive potential makes these cells an attractive therapeutic tool. The purpose of this 
study was to isolate, expand and characterize mesenchymal stem cell from human bone 
marrow in Mesenchymal Stem Cell Growth Medium (MSCGM), to compare the cell 
growth in the MSCGM and Dulbecco Modified Eagle‟s Medium (DMEM) with 10% 
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Fetal Bovine Serum (FBS) medium, to differentiate MSCs into osteoblast cells and to 
determine the osteogenic potential of the differentiated MSC by detecting the expression 
of osteoblast-specific genes such as collagen type 1, osteocalcin, runx 2, osteopontin and 
alkaline phosphatase. In this study, MSCs were isolated from human bone marrow and 
cultured in MSCGM medium and DMEM-10% FBS medium. Culture-expansion of 
MSCs was characterized by the presence of CD 105 marker using Labelled Streptavidin 
Biotin (LSAB) method. The MSCs were cultured in the MSCGM  and DMEM-10% FBS 
medium within five days. The MSCs were then cultured in osteogenic medium 
containing DMEM medium supplemented with Fetal Bovine Serum (FBS), antibiotics, 
ascorbic acid, β-glycerol phosphate and dexamethasone to differentiate into osteoblasts. 
Their osteogenic differentiation was determined with the formation of a mineralized 
extracellular matrix visualized by Von Kossa staining and Alkaline Phosphatase (ALP) 
assay. Moreover, osteogenic differentiation was also judge by RT-PCR profiling of 
osteoblast gene expression. MSC first attached to the dish surface and exhibited 
fibroblast-like spindle shape. The cells were also identified as MSCs based on their 
immunophenotype of CD 105 which resulted in funchia coloured staining. The MSCs 
culture in MSCGM medium expanded and proliferated rapidly compared to MSCs 
culture in DMEM-10% FBS medium. Incubation of bone marrow-derived MSCs in the 
osteogenic medium for 3 weeks resulted in a dramatic increase in ALP activity and 
accumulation of calcium deposit, as assessed by ALP assay and Von Kossa staining, 
respectively. This osteogenic potential upon culture in osteogenic medium was further 
confirmed by the RT-PCR analysis where the expressions of osteoblast specific genes 
were confirmed by molecular weight produced on agarose gel. We conclude that 
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MSCGM is the best choice for expanding and proliferating MSCs and suggest that MSC 
from bone marrow have pure osteogenic potential and have the capability to differentiate 
into osteoblast. This potential assures that bone marrow can be a legitimate source of 
MSCs for production of osteoblast which can be utilized in bone replacement therapy. 
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Setiap hari hampir beribu manusia mati menderita penyakit tulang disebabkan oleh 
kerosakan tisu tulang. Pelbagai jenis allograf, xenograf tulang dan tulang sintetik telah 
digunakan untuk terapi penggantian tulang. Pembinaan semula tulang bergantung kepada 
teknologi sel stem. Di dalam tulang sum-sum terdapat subset sel bukan hematopoitik 
yang dirujuk sebagai sel mesenkima atau generasi sel mesenkima. Sel-sel ini boleh 
dikembangbiakkan atau diaruhkan samada in vitro atau in vivo dan akhirnya bertukar 
kepada osteoblas, chondrosit, adiposit, tenosit, myotiub, sel neuro dan tisu penyokong 
hematopoitik. Oleh kerana sel ini mempunyai pelbagai potensi, mudah dikumpulkan dan 
dikultur, juga mempunyai daya kembang biak ex vivo yang tinggi, menjadikan sel ini 
sebagai satu alat terapeutik yang menarik. Tujuan kajian ini adalah untuk memencilkan, 
mengembang biakkan dan mencirikan sel mesenkima daripada tulang sum-sum di dalam 
media MSCGM, membandingkan perkembangan sel di dalam media MSCGM dan media 
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DMEM-10% FBS, menukarkan sel mesenkima kepada sel osteoblas dan menentukan 
kebolehan osteogenik sel mesenkima bertukar kepada sel osteoblas melalui ekspresi lima 
gen khusus osteoblas; collagen type 1, osteocalcin, runx 2, osteopontin dan alkaline 
phosphatase. Di dalam kajian ini sel stem mesenkima telah dipencilkan dan dikultur di 
dalam media MSCGM dan media DMEM-10% FBS. MSC kultur yang berkembang biak 
telah diuji sifat dan ciri-cirinya melalui kehadiran penanda permukaan sel CD 105 dengan 
kaedah Labelled Streptavidin Biotin (LSAB). Sel mesenkima telah dikultur di dalam 
media MSCGM dan juga media DMEM-10% FBS dalam lingkungan lima hari. Sel 
mesenkima kemudiannya dikulturkan di dalam media DMEM dengan tambahan Fetal 
Bovine Serum (FBS), antibiotic, askorbik asid, β-glycerol Phosphate dan dexamethasone 
untuk membezakan kepada sel osteoblas. Pembezaan osteogenik yang optimum telah 
ditentukan daripada pembentukan matrik mineral ekstraselular yang dilihat secara visual 
melalui tompokan Von Kossa dan pegujian Alkaline Phosphatase (ALP). Tambahan lagi 
pembezaan osteogenik telah diadili melalui ekspresi osteoblas gen profil RT-PCR. Sel 
mesenkima pada mulanya melekat pada permukaan bekas kultur dan menunjukkan 
bentuk seperti gelungan fibroblast. Sel ini juga telah dikenal pasti sebagai MSC 
berdasarkan pada immunofenotip (CD105), menyebabkan pewarnaan warna funchia. Sel 
mesenkima yang dikultur di dalam media MSCGM tumbuh dah berkembang biak dengan 
cepat berbanding dengan sel mesenkima yang dikultur di dalam media DMEM-10% FBS. 
Pengeraman MSC daripada sel tulang sum-sum di dalam media osteogenik selama tiga 
minggu menghasilkan peningkatan dalam aktiviti ALP dan pengumpulan mendapan 
kalsium melalui penilaian pengujian ALP dan tompokan Von Kossa. Potensi osteogenik 
telah disahkan lagi menggunakan analisis RT-PCR di mana ekspresi gen khusus telah 
 8 
menunjukkan jaluran DNA di atas gel agarose. Kami merumuskan bahawa media 
MSCGM adalah pilihan terbaik untuk pertumbuhan dan kembang biak sel mesenkima 
dan mencadangkan bahawa sel mesenkima daripada tulang sum-sum mempunyai potensi 
osteogenik yang tulen dan berkeupayaan untuk bertukar kepada sel osteoblas. Potensi 
mesengenic ini meyakinkan bahawa sel stem daripada tulang sum-sum adalah 
multipotensi MSCs dan menunjukkan bahawa tulang sum-sum merupakan sumber MSC 
yang sah untuk menghasilkan osteoblas yang dapat digunakan dalam terapi penggantian 
tulang. 
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CHAPTER 1 
 
INTRODUCTION 
 
A stem cell is a cell that has the ability to divide (self-replicate) for indefinite periods 
often throughout the life of the organism. Under the right conditions, or given the right 
signals, stem cells can give rise (differentiate) to the many different cell types that make 
up the organism. Stem cells have the potential to develop into mature cells that have 
characteristic shapes and specialized functions, such as bone cells, heart cells, skin cells 
or nerve cells (Chandross et al., 2001). 
 
Many of the terms used to define stem cells depend on the behavior of the cells in the 
intact organism (in vivo), under specific laboratory conditions (in vitro), or after 
transplantation in vivo, often to a tissue that is different from the one from which the stem 
cells were derived. For example, the fertilized egg is said to be totipotent from the latin 
word totus, meaning entire because it has the potential to generate all the cells and tissues 
that make up an embryo and that support its development in utero. The fertilized egg 
divides and differentiates until it produces a mature organism. The term pluripotent used 
to describe stem cells that can give rise to cells derived from all three embryonic germ 
layers; mesoderm, endoderm, and ectoderm. These three germ layers are the embryonic 
source of all cells of the body. All of the many different kinds of specialized cells that 
make up the body are derived from one of these germ layers. “Pluri” derived from the 
latin word plures that means several or many. Thus, pluripotent cells have the potential to 
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give rise to several type of cell, a property observed in the natural course of embryonic 
development and under certain laboratory conditions. Unipotent stem cell, a term usually 
applied to a cell in adult organisms, means that the cells in question are capable of 
differentiating along only one lineage. “Uni” is derived from the latin word unus, which 
means one. Also, it may be that the adult stem cells in many differentiated, undamaged 
tissues are typically unipotent and give rise to just one cell type under normal conditions. 
This process would allow for a steady state of self-renewal for the tissue. However, if the 
tissue becomes damaged and the replacement of multiple cell types is required, 
pluripotent stem cells may become activated to repair the damage. 
 
Embryonic stem cell and adult stem cell are two types of stem cell. The embryonic stem 
cell is defined by its origin that is from one of the earliest stages of the development of 
the embryo, called blastocyst. Specifically, embryonic stem cells are derived from the 
inner cell mass of the blastocyst at a stage before it would implant in the uterine wall. It 
can give rise to cells derived from all three germ layers. The adult stem cell is an 
undifferentiated (unspecialized) cell that is found in a differentiated (specialized) tissue; 
it can renew itself and become specialized to yield all of the specialized cell types of the 
tissue from which it originated. Adult stem cells have been found in the bone marrow, 
blood stream, cornea and retina of the eye, the dental pulp of the tooth, liver, skin, 
gastrointestinal tract, and pancreas (Slack et al., 2000). Unlike embryonic stem cells, at 
this point in time, there are no isolated adult stem cells that are capable of forming all 
cells of the body.  
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Adult stem cell compartment consists of two sub-populations which are hematopoietic 
stem cells (HMCs) and mesenchymal stem cells (MSCs). A hematopoietic stem cell is a 
cell that form blood and immune cells. They are responsible for the constant renewal of 
blood and the production of new blood cells each day. The cells are isolated from the 
blood or bone marrow that can renew itself, can differentiate to a variety of specialized 
cells, can mobilize out of the bone marrow into circulating blood, and can undergo 
programmed cell death, called apoptosis; a process by which cells that are detrimental or 
unneeded undergo self-destruct. Adult mesenchymal stem cells are adult human 
pluripotent progenitor cells found in bone marrow, peripheral blood, cord blood, adipose 
tissue and liver. They have self-renewal capacity without differentiation in long term 
culture. Under certain conditions, MSC could be differentiated into adipocytes, 
chondrocytes, astrocytes, tenocytes, cardiomyocytes, hepatocytes, neurons, muscle cells, 
endothelial and endodermal cells (Sanchez-Ramos et al., 2000). MSCs have generated a 
great deal of excitement and promise as a potential source of cells for cell-based 
therapeutic strategies, primarily owing to their intrinsic ability to self-renew and 
differentiate into functional cell types that constitute the tissue in which they exist. MSCs 
are considered a readily accepted source of stem cells because such cells have already 
demonstrated efficacy in multiple types of cellular therapeutic strategies, including 
applications in treating children with osteogenesis imperfecta (Horwitz et al., 2002), 
haematopoietic recovery (Koc et al., 2000), and bone tissue regeneration strategies (Petite 
et al., 2000). 
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Despite the great interest in MSC, there is still no established protocol for isolation and 
expansion of the cells in culture. In most experiments isolated MSC from bone marrow 
mononuclear cells were determined based on their tight adherence to tissue culture 
plastic. The isolated cells were initially heterogenous, and were difficult to be 
distinguished from other adherent cells. Several methods have been developed to prepare 
more homogenous populations but none of protocols have earned wide acceptance (Hung 
et al., 2002). However, today there are many studies have isolated MSCs and controlled, 
in vitro, its differentiation into cartilaginous tissue and bone using new technology for 
repairing injured tissues of mesenchymal origin (Renata et al., 2006) 
 
In this study, we have tried a method according to Friedenstein (1982) who was the first 
to identify a fibroblast-like cell in the bone marrow that can be cultured undifferentiated 
in vitro (Bruder et al., 1994) with modification in terms of media use and have 
succesfully differentiated it into bone cells. Bone formation in the embryo, and during 
adult fracture repair and remodeling, involves the progeny of cells called mesenchymal 
stem cells. These cells continuously replicate themselves, while a portion become 
commited to mesenchymal cell lineages such as bone, cartilage, tendon, ligament, and 
muscle. The differentiation of these cells, within each lineage, is a complex multistep 
pathway involving discrete cellular transitions much like that, which occurs during 
hematopoiesis. Progression from one stage to the next depends on the presence of 
specific bioactive factors, nutrient and other environmental cues whose exquisitely 
controlled contributions orchestrate the entire differentiation phenomenon (Price et al., 
1993). 
